U.S. markets closed

Enzon Pharmaceuticals, Inc. (ENZN)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.3687+0.0086 (+2.40%)
At close: 3:09PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 9/18/2021
Current
6/30/20213/31/202112/31/20209/30/20206/30/2020
Market Cap (intraday) 5
27.36M48.98M60.11M18.43M8.17M7.71M
Enterprise Value 3
-20.83M794.64k11.97M13.12M2.26M2.57M
Trailing P/E
N/AN/AN/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/AN/A
Price/Sales (ttm)
34.1389.74795.98163.93133.8829.66
Price/Book (mrq)
4.327.138.173.571.461.33
Enterprise Value/Revenue 3
-29.182.7331.42386.00282.18320.88
Enterprise Value/EBITDA 7
24.83-37.841.09k-31.10-5.55-10.88

Trading Information

Stock Price History

Beta (5Y Monthly) 0.27
52-Week Change 394.74%
S&P500 52-Week Change 335.11%
52 Week High 30.8500
52 Week Low 30.0200
50-Day Moving Average 30.4041
200-Day Moving Average 30.5822

Share Statistics

Avg Vol (3 month) 367.22k
Avg Vol (10 day) 333.3k
Shares Outstanding 574.21M
Implied Shares Outstanding 6N/A
Float 30.21M
% Held by Insiders 110.85%
% Held by Institutions 154.66%
Shares Short (May 12, 2016) 4259.38k
Short Ratio (May 12, 2016) 41.71
Short % of Float (May 12, 2016) 40.68%
Short % of Shares Outstanding (May 12, 2016) 40.59%
Shares Short (prior month Apr 14, 2016) 4298.38k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Oct 14, 2019
Ex-Dividend Date 4Sep 29, 2019
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021

Profitability

Profit Margin -117.79%
Operating Margin (ttm)-117.51%

Management Effectiveness

Return on Assets (ttm)-1.93%
Return on Equity (ttm)-3.15%

Income Statement

Revenue (ttm)714k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)3,537.50%
Gross Profit (ttm)52k
EBITDA N/A
Net Income Avi to Common (ttm)-2.31M
Diluted EPS (ttm)-0.0350
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)48.19M
Total Cash Per Share (mrq)0.65
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)111.17
Book Value Per Share (mrq)0.09

Cash Flow Statement

Operating Cash Flow (ttm)-794k
Levered Free Cash Flow (ttm)-477.38k